Michela Palleschi, Caterina Gianni, Filippo Merloni, Alberto Farolfi, Giulia Miserocchi, Nicola Gentili, Marita Mariotti, Giandomenico Di Menna, Olga Serra, Chiara Casadei, Francesca Rusconi, Alice Andalò, Simone Sabbioni, Andrea Carlini, Daniela Montanari, Marianna Sirico, Roberta Maltoni, Lorenzo Cecconetto, Samanta Sarti, Antonino Musolino. "Real-world survival benefit of glucagon-like peptide-1 receptor agonists (GLP-1 Ras) concomitant with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) and endocrine therapy in hormone receptor-positive (HR+)/HER2− metastatic breast cancer: A large propensity-matched analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1070